Reproductive health

Adventia is a state-of-the-art genetic screening test that can determine whether a person without symptoms is a carrier of a genetic disease. The genetic information provided by Adventia can help you make informed family planning decisions, reducing the risk of passing a genetic disease to your offspring. Adventia, a comprehensive panel, is a study that includes 231 genes associated with diseases with an autosomal recessive and X-chromosome-coupled inheritance model.

Adventia is a state-of-the-art genetic screening test that can determine whether a person without symptoms is a carrier of a genetic disease.

The description refers to the test in the basic panel version for a couple.

Adventia is a state-of-the-art genetic screening test that can determine whether a person without symptoms is a carrier of a genetic disease.

The description refers to the test in the version of the basic panel for one person.

VERACITY is a next-generation non-invasive prenatal test (NIPT) that accurately detects common chromosomal abnormalities. What is important - you will perform the test without leaving home! A qualified medical specialist will come to you, who will perform the intake and take care of the rest.

VERAgene is the first non-invasive, highly comprehensive prenatal screening test (NIPT) for aneuploidies, microdeletions, and point mutations. 
The VERAgene test can be performed as early as the 9th week of pregnancy. Now the sampling is at your home!

VERACITY is a next-generation non-invasive prenatal test (NIPT) that accurately detects common chromosomal abnormalities.

VERAgene is the first non-invasive, highly comprehensive prenatal screening test (NIPT) for aneuploidies, microdeletions, and point mutations. 
The VERAgene test can be performed as early as the 9th week of pregnancy.